11. FRI0199 Rituximab in Combination with Leflunomide: Results from A Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study). (15th July 2016) Authors: Behrens, F.; Rossmanith, T.; Köhm, M.; Alten, R.; Aringer, M.; Backhaus, M.; Baerwald, C.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.-P.; Wassenberg, S.; Burkhardt, H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. FRI0202 Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Specker, C.; Kaufmann, J.; Kellner, H.; Kästner, P.; Volberg, C.; Braunewell, V.; Aringer, A.; Sieburg, M.; Meier, L.; Hofmann, M.W.; Flacke, J.-P.; Tony, H.-P.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. FRI0222 Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Proposed Rituximab Biosimilar (GP2013) vs. EU-Approved Rituximab (RTX) in Patients with Rheumatoid Arthritis: Results from A Randomized Controlled Trial (GP13-201) over 52 Weeks. (15th July 2016) Authors: Smolen, J.; Scheinberg, M.; Tony, H.-P.; Zhu, P.; Shisha, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. SAT0056 Retro – Study of Reduction of Therapy in Patients with Rheumatoid Arthritis in Ongoing Remission. (9th June 2015) Authors: Haschka, J.; Englbrecht, M.; Hueber, A.J.; Manger, B.; Kleyer, A.; Reiser, M.; Finzel, S.; Tony, H.-P.; Kleinert, S.; Feuchtenberger, M.; Fleck, M.; Manger, K.; Ochs, W.; Schmitt-Haendle, M.; Wendler, J.; Schuch, F.; Ronneberger, M.; Lorenz, H.-M.; Nuesslein, H.; Alten, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. SAT0065 Effects of Dmard Tapering on Treatment Costs in Rheumatoid Arthritis Patients- An Analysis from The Prospective Randomized Controlled Retro- Study. (15th July 2016) Authors: Hagen, M.; Figueiredo, C.; Cobra, J.F.; Reiser, M.; Haschka, J.; Englbrecht, M.; Hueber, A.; Manger, B.; Kleyer, A.; Finzel, S.; Tony, H.-P.; Wendler, J.; Kleinert, S.; Schuch, F.; Ronneberger, M.; Feuchtenberger, M.; Fleck, M.; Manger, K.; Ochs, W.; Schmitt-Haendle, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. SAT0070 Association of Improvement in Pain with Therapeutic Response as Determined by Individual Significant Improvement Criteria in Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Scharbatke, E.; Behrens, F.; Schmalzing, M.; Koehm, M.; Greger, G.; Gnann, H.; Tony, H.-P.; Burkhardt, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. SAT0088 Identification of Patients at High Risk for Death in Rheumatic Disease. (23rd January 2014) Authors: Kleinert, S.; Breunig, M.; Tony, H.-P.; Feuchtenberger, M.; Kneitz, C.; Lehmann, S.; Angermann, C. E.; Ertl, G.; Störk, S. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. SAT0090 Impact of rheumatoid factor and anti-CCP antibodies on eular response to long-term treatment with rituximab in patients with rheumatoid arthritis after failing one TNFI (first and refirst). (23rd January 2014) Authors: Tony, H.-P.; Roll, P.; Mei, H.; Gnuegge, L.; Kandenwein, J.; Blümner, E.; Hammes, A.; Dörner, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. SAT0182 Tocilizumab s.c. – improvement of the depressiveness, fatigue and pain in ra therapy. (12th June 2018) Authors: Behrens, F.; Englbrecht, M.; Biewer, W. A.; Burmester, G.-R.; Feuchtenberger, M.; Flacke, J.-P.; Hofmann, M.; Kästner, P.; Kellner, H.; Klopsch, T.; Kühne, C.; Tony, H.-P.; Amberger, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. SAT0183 Patient Reported Outcomes (PRO) of the Mirai: Study of a Sequential Therapy of Tocilizumab and, If Initially Inadequately Responded to Tocilizumab, Followed by Rituximab in DMARD-IR Patients with Rheumatoid Arthritis (MIRAI). (9th June 2015) Authors: Iking-Konert, C.; Burmester, G.-R.; Dörner, T.; Schulze-Koops, H.; Rubbert-Roth, A.; Engel, A.; Gauler, G.; Schwenke, R.; Peters, M.A.; Tony, H.-P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗